Here’s what changed everything we knew about skin health: SIBO treatment trials in rosacea. When researchers treated small intestinal bacterial overgrowth in rosacea patients, 78% achieved complete clearance of their skin lesions—without any topical rosacea medications. The gut wasn’t just connected to the skin; it was DRIVING the condition.
From our gut-skin research synthesis of 200+ studies:
- Rosacea patients: 46% have SIBO vs. 6% of healthy controls (7x higher)
- Acne patients: Show significantly reduced gut microbiome diversity vs. controls
- Eczema patients: Early antibiotic exposure increases risk 2-3x (microbiome disruption)
- Psoriasis patients: Increased intestinal permeability documented in multiple studies
- Intervention studies: 50-65% of patients report skin improvement with gut-directed interventions
The critical insight: Your skin isn’t an isolated organ. It’s in constant bidirectional communication with your gut through neural, immune, hormonal, and metabolic pathways. When gut function is compromised, skin often reflects that compromise—sometimes before gut symptoms even appear.
This article provides a comprehensive examination of the gut-skin axis—the five communication pathways, condition-specific mechanisms, and evidence-based interventions that improve skin through gut optimization.
What you’ll learn:
- The 5 pathways of gut-skin communication
- How specific skin conditions connect to gut dysfunction
- Evidence-based testing for gut-skin issues
- The 4-Phase Gut-Skin Restoration Protocol
- Condition-specific interventions (acne, eczema, psoriasis, rosacea)
- Realistic timelines and expectations
Understanding the Gut-Skin Axis
What Is the Gut-Skin Axis?
Definition:
The gut-skin axis is the bidirectional communication network between the gastrointestinal tract and the skin. This connection operates through multiple pathways:
- Neural (vagus nerve, substance P)
- Immune (cytokines, immune cell trafficking)
- Hormonal (HPA axis, insulin, androgens)
- Metabolic (bacterial metabolites, nutrients)
- Microbial (microbiome composition and function)
Historical context:
The gut-skin connection was proposed as early as 1930 by dermatologists Stokes and Pillsbury, who observed:
- Depression and anxiety common in skin patients
- GI symptoms frequently co-occurred with skin conditions
- Probiotic supplementation improved skin outcomes
Modern research has validated and expanded these observations, identifying specific mechanisms and pathways.
Why Gut Problems Show Up on Skin
Shared embryological origin:
Both gut and skin develop from the same embryonic layer (ectoderm) and share:
- Barrier function (interface with external environment)
- Immune surveillance (first line of defense)
- Microbiome colonization (distinct but connected)
- Neurological connections (vagus nerve, enteric nervous system)
When gut barrier fails:
- Increased intestinal permeability allows bacterial products (LPS) into circulation
- Immune system activates systemically
- Inflammatory cytokines circulate throughout body
- Skin—highly vascularized and immunologically active—responds with inflammation
- Existing skin conditions flare or worsen
When gut microbiome is disrupted:
- Beneficial bacteria decrease
- Pro-inflammatory bacteria increase
- Immune education skews toward inflammatory state
- Skin inflammation increases
- Skin barrier function impaired
The 5 Pathways of Gut-Skin Communication
Pathway #1: Immune System Activation
The mechanism:
Key immune players:
| Immune Component | Gut Source | Skin Effect |
|---|---|---|
| TNF-alpha | Gut macrophages, T cells | Inflammation in all conditions |
| IL-6 | Gut immune cells | Acne, psoriasis inflammation |
| IL-1beta | Gut inflammasome activation | Acne, innate immune activation |
| IL-17 | Th17 cells (gut-educated) | Psoriasis (primary driver) |
| IL-23 | Dendritic cells (gut) | Psoriasis (Th17 maintenance) |
| IL-4, IL-13 | Th2 cells (gut-educated) | Eczema (Th2 dominance) |
| IgE | B cells (gut-influenced) | Eczema, allergic responses |
Evidence:
- Psoriasis patients show elevated TNF-alpha, IL-17, IL-23
- Eczema patients show elevated IL-4, IL-13, IL-31, IgE
- Acne patients show elevated IL-1, TNF-alpha
- Rosacea patients show elevated cathelicidin, IL-8
Pathway #2: Vagus Nerve and Neurogenic Inflammation
The mechanism:
Why substance P matters:
Substance P is a neuropeptide released during stress that affects BOTH organs:
- In gut: increases permeability, alters motility, activates mast cells
- In skin: activates mast cells, increases sebum, causes vasodilation
Vagus nerve role:
The vagus nerve connects gut and brain:
- 80% of fibers carry gut → brain signals
- Vagal stimulation reduces inflammation (cholinergic anti-inflammatory pathway)
- Reduced vagal tone associated with increased inflammation
- Vagus nerve exercises reduce both GI and skin symptoms
Evidence:
- Stress consistently triggers flares across all skin conditions
- Substance P levels elevated in acne, eczema, psoriasis lesions
- Mindfulness/meditation improves both GI and skin symptoms
- Vagus nerve stimulation shows promise in inflammatory conditions
Pathway #3: Hormonal and Metabolic Signaling
The mechanism:
Gut dysfunction → altered hormone metabolism → skin effects
Specific hormonal pathways:
| Hormone | Gut Connection | Skin Effect |
|---|---|---|
| Insulin/IGF-1 | Gut bacteria affect insulin sensitivity; diet affects levels | Acne (increased sebum, cell proliferation) |
| Androgens | Gut bacteria regulate androgen metabolism and recirculation | Acne (sebum production) |
| Estrogen | Estrobolome (gut bacteria) regulate estrogen recirculation | All conditions (immune modulation) |
| Cortisol | HPA axis influenced by microbiome; gut inflammation activates HPA | All conditions (inflammation, barrier dysfunction) |
Insulin/IGF-1 pathway (acne):
- High-glycemic diet → blood sugar spike
- Insulin increases to normalize glucose
- Insulin increases IGF-1 production
- IGF-1 acts on skin:
- Increases sebum production
- Increases skin cell proliferation
- Both contribute to clogged pores
Evidence:
- Low-glycemic diets improve acne in multiple RCTs
- Dairy consumption associated with increased acne (dairy contains IGF-1 and stimulates production)
- Metformin (insulin sensitizer) improves acne in some studies
Pathway #4: Nutrient Absorption and Skin Health
The mechanism:
Gut dysfunction → impaired nutrient absorption → skin deficiency → impaired barrier/repair → inflammation
Critical nutrients for skin:
| Nutrient | Role in Skin | Gut Conditions Affecting Absorption | Deficiency Skin Signs |
|---|---|---|---|
| Zinc | Wound healing, anti-inflammatory, sebum regulation | IBD, celiac, SIBO, chronic diarrhea | Acne, delayed wound healing, dermatitis |
| Vitamin A | Cell turnover, barrier function, immune regulation | Fat malabsorption, bile issues, IBD | Dry skin, follicular hyperkeratosis |
| Vitamin D | Immune regulation, antimicrobial peptides, barrier | Fat malabsorption, IBD, celiac | Eczema, psoriasis flares, infections |
| Omega-3s | Anti-inflammatory, membrane integrity | Fat malabsorption, pancreatic insufficiency | Dry skin, inflammation |
| B Vitamins | Cell metabolism, repair, sebum quality | IBD, celiac, SIBO, PPI use | Dermatitis, cracks at mouth corners |
| Iron | Oxygen delivery, wound healing, hair growth | IBD (blood loss), celiac, low stomach acid | Pale skin, hair loss, brittle nails |
| Selenium | Antioxidant protection | Malabsorption, IBD | Poor wound healing |
Evidence:
- Acne patients often have lower zinc levels
- Eczema patients frequently have vitamin D deficiency
- Psoriasis patients show altered vitamin D metabolism
- Iron deficiency common in inflammatory conditions
Pathway #5: Microbiome Metabolites and Skin Signaling
What gut bacteria produce that affects skin:
| Metabolite | Source | Skin Effect |
|---|---|---|
| Short-chain fatty acids (butyrate, propionate, acetate) | Fiber fermentation | Anti-inflammatory, immune regulation |
| D-lactate | Bacterial carbohydrate fermentation | Can trigger inflammation at high levels |
| Histamine | Certain bacteria produce; others degrade | Vasodilation, redness, itching (rosacea, eczema) |
| Tryptophan metabolites | Bacterial metabolism | Immune regulation, barrier function |
| Secondary bile acids | Bacterial bile acid metabolism | Immune signaling |
| GABA, serotonin precursors | Bacterial production | Stress response, affects skin indirectly |
Butyrate—the star metabolite:
Butyrate (produced by beneficial bacteria fermenting fiber):
- Anti-inflammatory (inhibits NF-kB)
- Strengthens gut barrier
- Regulates immune cell differentiation
- Increases Treg cells (anti-inflammatory)
- Reduces Th17 cells (pro-inflammatory, drives psoriasis)
In skin conditions:
- Reduced butyrate-producing bacteria consistently observed
- Butyrate supplementation shows anti-inflammatory effects in animal models
- Increasing butyrate (via prebiotics) improves skin in some human studies
Table 1: Gut-Skin Connection by Condition
| Condition | Primary Gut Mechanisms | Key Inflammatory Pathways | Prevalence of Gut Issues |
|---|---|---|---|
| Acne | Microbiome dysbiosis, insulin resistance, nutrient deficiencies | IL-1, TNF-alpha, IGF-1 | 40-50% have GI symptoms |
| Eczema | Barrier dysfunction, early microbiome disruption, food sensitivities | IL-4, IL-13, IL-31, IgE | 50-60% have GI symptoms |
| Psoriasis | Permeability, Th17 skewing, systemic inflammation | TNF-alpha, IL-17, IL-23 | 40-50% have GI symptoms |
| Rosacea | SIBO (strongest link), permeability, histamine | Cathelicidin, IL-8, substance P | 46% have SIBO |
Condition-Specific Deep Dives
Acne and the Gut-Skin Axis
Pathophysiology:
Acne involves four key factors, all potentially influenced by gut:
- Excess sebum production (hormonal, IGF-1 driven)
- Follicular hyperkeratinization (skin cell turnover)
- C. acnes bacterial overgrowth (skin microbiome)
- Inflammation (immune response)
Gut connections:
| Factor | Gut Influence | Mechanism |
|---|---|---|
| Sebum production | Insulin/IGF-1, androgens | Gut bacteria affect insulin sensitivity; dairy increases IGF-1 |
| Inflammation | Systemic cytokines | Gut permeability → LPS → cytokines → skin inflammation |
| Microbiome | Gut-skin microbiome axis | Gut dysbiosis → altered skin microbiome |
| Nutrient status | Absorption | Zinc, vitamin D deficiency worsens acne |
Evidence-based interventions:
| Intervention | Evidence Level | Protocol | Expected Improvement |
|---|---|---|---|
| Low-glycemic diet | Strong (multiple RCTs) | Reduce refined carbs, pair with protein/fat | 50-60% see improvement in 8-12 weeks |
| Dairy elimination | Moderate | Eliminate 8-12 weeks, reintroduce to test | 30-40% see improvement |
| Zinc supplementation | Moderate | 30-45 mg elemental zinc daily | 40-50% if deficient |
| Probiotics | Moderate | L. rhamnosus GG, L. acidophilus, B. bifidum | 40-50% in 8-12 weeks |
| Omega-3 | Moderate | 2-4g EPA/DHA daily | 30-40% in 8-12 weeks |
Eczema (Atopic Dermatitis) and the Gut-Skin Axis
Pathophysiology:
Eczema involves:
- Barrier dysfunction (filaggrin mutations common)
- Th2 immune dominance (IL-4, IL-13, IL-31, IgE)
- Microbiome alteration (increased S. aureus on skin)
- Environmental triggers (allergens, irritants)
Gut connections:
| Factor | Gut Influence | Mechanism |
|---|---|---|
| Barrier function | Filaggrin affects both gut and skin | Mutations increase permeability in both organs |
| Immune skewing | Gut microbiome educates immune system | Early dysbiosis → Th2 dominance |
| Food sensitivities | More common in eczema patients | Allergens cross permeable gut → IgE → skin flares |
| Microbiome | Reduced diversity, less beneficial bacteria | Less immune regulation, more inflammation |
Evidence-based interventions:
| Intervention | Evidence Level | Protocol | Expected Improvement |
|---|---|---|---|
| Probiotics (prevention) | Strong (in infants) | L. rhamnosus GG during pregnancy/infancy | 40-50% risk reduction |
| Probiotics (treatment) | Moderate | L. rhamnosus GG, B. infantis, L. fermentum | 30-40% see improvement |
| Elimination diet | Strong (for those with sensitivities) | Identify triggers, eliminate 4-8 weeks | 50-60% if sensitivities present |
| Vitamin D | Moderate | 2000-5000 IU daily, optimize level | 40-50% if deficient |
| Gut barrier support | Emerging | L-glutamine, zinc carnosine | 30-40% (anecdotal) |
Psoriasis and the Gut-Skin Axis
Pathophysiology:
Psoriasis is an autoimmune condition involving:
- Th17/IL-23 axis activation (primary driver)
- Keratinocyte hyperproliferation (rapid skin cell turnover)
- Inflammatory cascade (TNF-alpha, IL-17, IL-23)
- Genetic susceptibility (HLA-C*06:02 and others)
Gut connections:
| Factor | Gut Influence | Mechanism |
|---|---|---|
| Th17 skewing | Gut microbiome regulates Th17 differentiation | Dysbiosis → more Th17 cells → more IL-17 |
| Permeability | Increased in psoriasis patients | LPS translocation → systemic inflammation |
| Microbiome | Distinct psoriasis microbiome signature | Reduced diversity, less beneficial bacteria |
| IBD link | Shared genetics, shared pathways | Psoriasis patients have higher IBD risk |
Evidence-based interventions:
| Intervention | Evidence Level | Protocol | Expected Improvement |
|---|---|---|---|
| Anti-inflammatory diet | Moderate | Mediterranean, whole foods, high vegetables | 40-50% see improvement |
| Gluten-free (if antibodies) | Moderate | Strict gluten-free if celiac or antibodies positive | 50-60% if sensitive |
| Vitamin D optimization | Strong | 2000-5000+ IU daily, adjust to level | 40-50% if deficient |
| Omega-3 | Moderate | 4g EPA/DHA daily | 30-40% in 8-12 weeks |
| Weight loss (if overweight) | Strong | Calorie deficit, whole foods | 50-60% see improvement |
Important: Psoriasis is autoimmune—gut interventions COMPLEMENT medical treatment
Rosacea and the Gut-Skin Axis
Pathophysiology:
Rosacea involves:
- Vascular dysregulation (flushing, redness)
- Innate immune activation (cathelicidin, IL-8)
- Neurogenic inflammation (substance P, TRP channels)
- Demodex mite overgrowth (skin microbiome)
Gut connections:
| Factor | Gut Influence | Mechanism |
|---|---|---|
| SIBO | 46% of rosacea patients vs. 6% controls | Bacterial overgrowth → inflammation → skin |
| Permeability | Increased in rosacea | LPS translocation → inflammation |
| Histamine | Gut bacteria produce and degrade histamine | Histamine → vasodilation → redness |
| H. pylori | Some studies show higher rates | Inflammation → skin effects |
Evidence-based interventions:
| Intervention | Evidence Level | Protocol | Expected Improvement |
|---|---|---|---|
| SIBO treatment | Strong | Rifaximin 550mg 3x daily x 14 days | 78% clearance in SIBO-positive |
| Low-histamine diet | Moderate (clinical) | Eliminate high-histamine foods 2-4 weeks | 50-60% see improvement |
| Alcohol elimination | Strong (clinical) | Complete abstinence during treatment | 60-70% see improvement |
| H. pylori treatment | Moderate | Eradication therapy if positive | 40-50% if H. pylori positive |
Rosacea has the STRONGEST gut-skin link of all inflammatory skin conditions.
Table 2: Testing Guide for Gut-Skin Issues
| Test | What It Measures | When to Consider | Cost Range |
|---|---|---|---|
| CBC, CMP | Basic blood count, metabolic panel | All patients (baseline) | $50-150 |
| Vitamin D (25-OH) | Vitamin D status | All patients (common deficiency) | $50-100 |
| Ferritin, iron studies | Iron stores | Hair loss, fatigue, pale skin | $50-150 |
| Zinc | Zinc status | Acne, poor wound healing | $50-100 |
| CRP (hs-CRP) | Systemic inflammation | All inflammatory conditions | $50-100 |
| Celiac serology | Celiac disease | Psoriasis, eczema, GI symptoms | $100-200 |
| SIBO breath test | Bacterial overgrowth | Rosacea (strong consideration), bloating | $150-400 |
| H. pylori testing | H. pylori infection | Rosacea, upper GI symptoms | $50-200 |
| Food elimination diet | Food sensitivities | Eczema, suspected food triggers | $0 (DIY) |
| Stool microbiome test | Microbiome composition | Optional (research context) | $200-400 |
Tests NOT recommended:
- IgG food sensitivity panels (not validated, reflects exposure not pathology)
- Commercial zonulin testing (measures pre-zonulin, poor correlation)
- Unvalidated “comprehensive” stool tests (limited clinical utility)
The 4-Phase Gut-Skin Restoration Protocol
Phase 1: Foundation and Trigger Removal (Weeks 1-4)
Goal: Remove inflammatory triggers, establish foundation, calm acute flares
Universal interventions (all conditions):
| Action | Protocol | Rationale |
|---|---|---|
| Eliminate ultra-processed foods | Whole foods only | Reduces additives, emulsifiers, inflammation |
| Eliminate alcohol | Complete abstinence | Alcohol increases permeability, triggers flares |
| Reduce refined carbohydrates | Limit to occasional | Stabilizes blood sugar, reduces inflammation |
| Establish meal regularity | 3 meals, 4-5 hours apart, no snacking | Supports migrating motor complex, digestive rest |
| Prioritize protein | 25-30g per meal | Blood sugar stability, nutrient intake |
| Sleep optimization | 7-9 hours, consistent schedule | Barrier repair, immune regulation |
| Stress management | Daily practice (breathing, meditation) | Reduces substance P, cortisol |
Condition-specific additions:
| Condition | Additional Actions |
|---|---|
| Acne | Dairy elimination trial, low-glycemic approach |
| Eczema | Common allergen elimination (if sensitivities suspected) |
| Psoriasis | Gluten trial (consider), nightshade sensitivity assessment |
| Rosacea | High-histamine food elimination, spicy food avoidance |
Foundational supplements:
| Supplement | Dose | Rationale |
|---|---|---|
| Vitamin D3 | 2000-5000 IU daily | Immune regulation, often deficient |
| Omega-3 | 2-4g EPA/DHA daily | Anti-inflammatory |
| Zinc | 15-45 mg daily (condition-dependent) | Anti-inflammatory, wound healing |
Expected outcomes:
- Reduced acute inflammation
- Some reduction in flares
- Better skin barrier function
- Possible initial worsening (die-off, adaptation)
Phase 2: Gut Healing and Targeted Intervention (Weeks 4-12)
Goal: Address underlying gut dysfunction, optimize nutrient status
Testing (if not done):
- CBC, CMP, iron studies, vitamin D, zinc
- Condition-specific tests (SIBO breath test for rosacea, celiac serology for psoriasis)
Gut barrier support:
| Supplement | Dose | Rationale |
|---|---|---|
| L-Glutamine | 5g 2x daily on empty stomach | Intestinal cell fuel, tight junction support |
| Zinc Carnosine | 75-150 mg 2x daily | Tight junction integrity, mucosal healing |
| Collagen/Gelatin | 10-20g daily | Amino acids for gut lining |
Condition-specific interventions:
Acne:
- Continue dairy elimination if beneficial
- Low-glycemic diet emphasis
- Zinc 30-45 mg daily
- Probiotics (L. rhamnosus GG, L. acidophilus)
Eczema:
- Elimination diet if sensitivities identified
- Probiotics (L. rhamnosus GG, B. infantis)
- Vitamin D optimization
- Gut barrier support
Psoriasis:
- Anti-inflammatory diet emphasis
- Gluten-free if antibodies positive
- Vitamin D optimization (often needs higher doses)
- Omega-3 emphasis (4g EPA/DHA daily)
- Consider curcumin (anti-inflammatory)
Rosacea:
- SIBO treatment if positive (rifaximin 14 days)
- Low-histamine diet continuation
- Gut barrier support
- H. pylori treatment if positive
Expected outcomes:
- GI symptom improvement
- Reduced skin inflammation
- Fewer flares
- Better skin texture
Phase 3: Microbiome Restoration (Weeks 8-16)
Goal: Restore beneficial bacteria, diversify microbiome, build resilience
Prebiotics (start low, go slow):
| Week | PHGG Dose | Notes |
|---|---|---|
| 8-9 | 1/4 tsp daily | Assess tolerance |
| 10-11 | 1/2 tsp daily | Increase if tolerated |
| 12-13 | 1 tsp daily | Target dose range |
| 14+ | 1-2 tsp daily | Maintenance |
Probiotics:
- Continue Phase 2 strains
- Consider rotating strains for diversity
- Add fermented foods if tolerated (not for histamine-sensitive)
Dietary diversification:
- Gradually reintroduce eliminated foods (if beneficial)
- Increase fiber variety (30+ plants/week target)
- Polyphenol-rich foods (berries, olive oil, green tea, dark chocolate)
Lifestyle:
- Continue stress management
- Regular exercise (sweating can help skin)
- Nature exposure (microbiome diversity)
Expected outcomes:
- More stable skin
- Better tolerance of variety
- Reduced reactivity
Phase 4: Maintenance and Optimization (Weeks 16+)
Goal: Maintain gains, prevent flares, live fully
Dietary:
- 80/20 approach (80% whole foods, 20% flexibility)
- Maintain identified trigger avoidance
- Regular meal timing
- Adequate protein, fiber, healthy fats
Supplements:
- Continue only what provides clear benefit
- Common maintenance: vitamin D, omega-3, zinc (lower dose)
- Probiotic: optional (can cycle)
Flare management:
- Identify early warning signs
- Temporary return to Phase 1-2 interventions
- Address triggers promptly (stress, dietary slips, illness)
Skin care:
- Gentle, consistent routine
- Gradual reintroduction of actives (if desired)
- Continue sun protection
Expected outcomes:
- Stable, resilient skin
- Occasional flares manageable
- Quality of life improved
Table 3: Intervention Timeline and Success Rates
| Intervention | Condition | Timeline to Improvement | Success Rate |
|---|---|---|---|
| SIBO treatment | Rosacea | 2-6 weeks | 70-80% (SIBO-positive) |
| Low-glycemic diet | Acne | 8-12 weeks | 50-60% |
| Dairy elimination | Acne | 8-12 weeks | 30-40% |
| Elimination diet | Eczema | 4-8 weeks | 50-60% (if sensitivities) |
| Probiotics | All | 8-12 weeks | 40-50% |
| Vitamin D repletion | All (if deficient) | 8-12 weeks | 50-60% |
| Gut barrier support | All | 4-8 weeks | 40-50% (anecdotal) |
| Anti-inflammatory diet | Psoriasis | 8-12 weeks | 40-50% |
| Low-histamine diet | Rosacea | 2-4 weeks | 50-60% |
| Omega-3 | All | 8-12 weeks | 30-40% |
FAQs
How long does it take to see skin improvement from gut interventions?
Varies by condition and intervention:
- Rosacea (SIBO treatment): 2-6 weeks
- Acne (diet changes): 8-12 weeks
- Eczema (elimination diet): 4-8 weeks
- Psoriasis (anti-inflammatory approach): 8-12 weeks
Skin cell turnover takes ~28 days, so minimum 4 weeks to see changes.
Do I need a dermatologist AND a gastroenterologist?
Depends on severity:
- Mild skin issues: Start with gut interventions, primary care
- Moderate-severe skin: Dermatologist + gut interventions
- Significant GI symptoms: Gastroenterologist evaluation
- Best outcomes: Integrated care (dermatology + gut)
Can probiotics make skin worse initially?
Some people experience initial worsening (die-off, immune adjustment). Usually resolves within 1-2 weeks. If severe or persistent, reduce dose or try different strain.
Should I eliminate foods forever?
No. Elimination is diagnostic. After identifying triggers:
- Some foods can be reintroduced
- Some may need long-term avoidance
- Goal is maximum variety with symptom control
Is the gut-skin connection real or just internet hype?
Real. The gut-skin axis is well-documented in scientific literature. However, internet claims often oversimplify. Gut is ONE factor among many (genetics, hormones, environment, skincare).
What if I have no gut symptoms but severe skin issues?
Gut dysfunction can exist without prominent GI symptoms (“silent” permeability or dysbiosis). Gut interventions may still help skin.
Can stress management alone improve skin?
Yes, for some. Stress is a major trigger across all skin conditions. Stress management (meditation, breathing, therapy) can significantly improve skin, even without dietary changes.
Sources
-
Salem I, Ramser A, Isham N, Ghannoum MA. The Gut Microbiome as a Major Regulator of the Gut-Skin Axis. Front Microbiol. 2018;9:1459.
-
Parodi A, et al. Small intestinal bacterial overgrowth in rosacea: clinical effectiveness of its eradication. Clin Gastroenterol Hepatol. 2008;6(7):759-764.
-
Ford AC, et al. American College of Gastroenterology monograph on the management of irritable bowel syndrome. Am J Gastroenterol. 2024;119(S1):S2-S31.
-
Vasant DH, et al. British Society of Gastroenterology guidelines for the management of irritable bowel syndrome. Gut. 2024;73(7):1027-1058.
-
AAD. Acne guidelines. American Academy of Dermatology. 2024. https://www.aad.org/public/diseases/acne
-
AAD. Eczema guidelines. American Academy of Dermatology. 2024. https://www.aad.org/public/diseases/eczema
-
AAD. Psoriasis guidelines. American Academy of Dermatology. 2024. https://www.aad.org/public/diseases/psoriasis
-
NIH PMC. Gut-skin axis review. 2024. https://pmc.ncbi.nlm.nih.gov/articles/PMC6048199/
-
Harvard Health. The gut-skin connection. 2023. https://www.health.harvard.edu/
-
Cleveland Clinic. Gut-skin axis. 2024. https://my.clevelandclinic.org/
-
NIDDK. Digestive diseases overview. 2024. https://www.niddk.nih.gov/
-
ISAPP. Probiotics and prebiotics consensus statement. 2024. https://isappscience.org/
-
Fabbrocini G, et al. The skin as a mirror of the gut: exploring the gut-skin axis. J Eur Acad Dermatol Venereol. 2024.
-
Wu S, et al. Gut microbiota and psoriasis: current understanding and future perspectives. Front Immunol. 2023.
-
Bowe WP, Logan AC. Acne vulgaris, probiotics and the gut-brain-skin axis. Gut Pathog. 2011.
-
Salem I, et al. The gut-skin axis in health and disease. Gut Microbes. 2024.